Literature DB >> 22670172

Lentivirus-mediated RNAi knockdown of VEGFA in RKO colorectal cancer cells decreases tumor formation and growth in vitro and in vivo.

Jiang-Feng Qiu1, Zhi-Qi Zhang, Yong Wang, Jun You.   

Abstract

Vascular endothelial growth factors (VEGF) play important roles in angiogenesis, vasculogenesis and endothelial cell growth. In endothelial cancers, secreted VEGF proteins induce endothelial cell proliferation, promote cell migration, inhibit apoptosis and induce blood vessel permeabilization. VEGFA is frequently overexpressed in human colorectal cancers (CRC) and its expression correlates with tumor progression and invasiveness. In this study we examine the effect of knocking down VEGFA expression by infecting RKO colorectal cancer cells with lentiviral particles containing VEGFA-targeting RNAi constructs. We found that suppressing VEGFA dramatically decreased RKO cell proliferation, colony formation, invasion, migration and tumor growth. Furthermore, VEGFA knock-down reduced MAPK pathway signaling and Smac/DIABLO expression. These results suggest that lentivirus-mediated RNAi knock-down of VEGFA could be an effective therapy for the treatment of CRC.

Entities:  

Keywords:  colorectal cancer; knock-down; lentivirus; shRNA; vascular endothelial growth factor A

Mesh:

Substances:

Year:  2011        PMID: 22670172      PMCID: PMC3365827     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

Review 1.  Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).

Authors:  Fumin Chang; Linda S Steelman; John G Shelton; John T Lee; Patrick M Navolanic; William L Blalock; Richard Franklin; James A McCubrey
Journal:  Int J Oncol       Date:  2003-03       Impact factor: 5.650

2.  Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer.

Authors:  M Volm; R Koomägi; J Mattern
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

3.  Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.

Authors:  Mark S Duxbury; Evan Matros; Hiromichi Ito; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

4.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Authors:  Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

5.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

6.  Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.

Authors:  Ferdinando De Vita; Michele Orditura; Eva Lieto; Stefania Infusino; Floriana Morgillo; Erika Martinelli; Paolo Castellano; Ciro Romano; Fortunato Ciardiello; Giuseppe Catalano; Carlo Pignatelli; Gennaro Galizia
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

7.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

8.  Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.

Authors:  Y Ohta; Y Endo; M Tanaka; J Shimizu; M Oda; Y Hayashi; Y Watanabe; T Sasaki
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

9.  Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.

Authors:  H Yoshiji; D E Gomez; M Shibuya; U P Thorgeirsson
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

10.  Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer.

Authors:  S I Ishigami; S Arii; M Furutani; M Niwano; T Harada; M Mizumoto; A Mori; H Onodera; M Imamura
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more
  4 in total

1.  [Construction of a lentiviral vector carrying short?hairpin RNA targeting PAX6 and its effect on proliferation of glioma U251 cells in vitro].

Authors:  Xiao-Hong Liao; Wei-Lan Yin; Fang Wang; Li-Xiang Wu; Bai-Sheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  LncRNA SNHG5 upregulation induced by YY1 contributes to angiogenesis via miR-26b/CTGF/VEGFA axis in acute myelogenous leukemia.

Authors:  Zhen-Jiang Li; Jing Cheng; Yuan Song; Hui-Hui Li; Ji-Fu Zheng
Journal:  Lab Invest       Date:  2020-12-14       Impact factor: 5.662

Review 3.  Recent Advances in the Development of Exogenous dsRNA for the Induction of RNA Interference in Cancer Therapy.

Authors:  Tatiana S Golubeva; Viktoria A Cherenko; Konstantin E Orishchenko
Journal:  Molecules       Date:  2021-01-29       Impact factor: 4.411

4.  Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma.

Authors:  Fan-Chang Zeng; Ming-Qiang Zeng; Liang Huang; Yong-Lin Li; Ben-Min Gao; Jun-Jie Chen; Rui-Zhi Xue; Zheng-Yan Tang
Journal:  Onco Targets Ther       Date:  2016-04-12       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.